Risedronate sodium - Osteoporosis
You are here : Home > Formulary Search > Risedronate sodium - Osteoporosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Preferred
Weekly tablets are 35mg. Daily tablets are 5mg.
NOTE - 30mg tablets are licensed for Paget's disease only
Documentation
Guidelines (Local)
Guidelines (Local)
NICE Technology Appraisal
PAD Profile
ChemicalSubstance :
Risedronate sodium
Indication :
Osteoporosis
Group Name :
Keywords :
Bisphosphonates, postmenopausal osteoporosis, risedronate weekly
Brand Names Include :
Actonel once a week, Actonel
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4
Other Indications
Below are listed other indications that Risedronate sodium is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Osteoporosis.
Committee Recommendations (1)
GENERIC Risedonate sodium has been considered by the PCN and has been assigned a GREEN traffic light status. NOTE - the branded product, Actonel, was considered BLACK at the PCN in May 2017.